Vestcor Inc’s TriSalus Life Sciences TLSI Stock Holding History

Vestcor Inc’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,376	Closed	-$109K	–	1236
2025 Q3	$109K	Hold	23,376	–	–	﹤0.01%	1078
2025 Q2	$127K	Hold	23,376	–	–	﹤0.01%	1040
2025 Q1	$129K	Hold	23,376	–	–	﹤0.01%	1032
2024 Q4	$117K	Hold	23,376	–	–	﹤0.01%	1077
2024 Q3	$108K	Buy	+23,376	New	+$124K	﹤0.01%	1051
2022 Q4	–	Sell	-276,074	Closed	-$2.74M	–	1322
2022 Q3	$2.74M	Hold	276,074	–	–	0.1%	209
2022 Q2	$2.72M	Hold	276,074	–	–	0.1%	236
2022 Q1	$2.71M	Hold	276,074	–	–	0.09%	246
2021 Q4	$2.73M	Hold	276,074	–	–	0.1%	217
2021 Q3	$2.74M	Hold	276,074	–	–	0.1%	236
2021 Q2	$2.69M	Buy	276,074 +233,772	+553%	+$2.29M	0.09%	243
2021 Q1	$408K	Buy	+42,302	New	+$429K	0.02%	654

Other funds holding TLSI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vestcor Inc's TLSI Position: Q4 2025 in Review

Vestcor Inc sold out of TriSalus Life Sciences (TLSI) in Q4 2025, closing a stake of 23,376 shares — an estimated $109K sold.

Vestcor Inc first reported a position in TLSI in Q1 2021 and held it in 12 quarters. The position peaked at $2.74M in Q3 2022. 67 funds tracked by Wall St. Rank hold TLSI as of Q4 2025.

Vestcor Inc reported no remaining TriSalus Life Sciences position as of Q4 2025 after selling out during the quarter.
Vestcor Inc sold 23,376 TriSalus Life Sciences shares in Q4 2025, an estimated $109K.
Vestcor Inc first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 12 quarters.
Vestcor Inc's TriSalus Life Sciences position peaked at $2.74M in Q3 2022.
67 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2025.

Based on Vestcor Inc's 13F filing for Q4 2025, filed 11 Feb 2026.